Jan Frederik Wenkel

Title: Innovations by Jan Frederik Wenkel

Introduction

Jan Frederik Wenkel is an accomplished inventor based in Montreal, Canada. He has made significant contributions to the field of technology, particularly in the area of neural networks and digital cell generation. His innovative work has led to the development of a unique patent that showcases his expertise and creativity.

Latest Patents

Jan Frederik Wenkel holds a patent titled "Generating virtual perturbed cells utilizing a latent transfer perturbation neural network." This patent involves systems, non-transitory computer-readable media, and methods for generating a digital perturbed cell with a plurality of virtual perturbed cell response features. The invention focuses on a flexible, modular latent transfer perturbation neural network that accurately generates virtual perturbed cells. The systems utilize a base state neural network to create a control cell latent representation based on a control cell, and a perturbation neural network to generate a perturbation latent representation based on a multi-perturbation data object. Ultimately, the systems combine these representations and apply a neural network decoder to generate virtual perturbed cell response features. Jan holds 1 patent in total.

Career Highlights

Jan Frederik Wenkel is currently employed at Recursion Pharmaceuticals, Inc., where he continues to push the boundaries of innovation in the pharmaceutical and biotechnology sectors. His work at Recursion Pharmaceuticals focuses on leveraging advanced technologies to enhance drug discovery and development processes.

Collaborations

Jan has collaborated with notable colleagues, including Alisandra Kaye Denton and Berton Allen Earnshaw. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking technologies.

Conclusion

Jan Frederik Wenkel is a prominent inventor whose work in generating virtual perturbed cells has the potential to revolutionize the field of biotechnology. His contributions reflect a commitment to innovation and excellence in technology.